Duke opens clinical research unit
A new hospital-based clinical research facility, Duke Clinical Research Unit (DCRU), has opened at Duke University Medical Center, Durham, N.C., for the clinical development and evaluation of investigational drugs and medical devices.

The DCRU will become a hospital-based, early phase research unit that will apply technologies, as well as advanced imaging, cell therapy, biobanking, immune monitoring and EchoMRI systems, to research, said the university.

One of the first studies underway in the DCRU is a study designed with the goal of personalizing aspirin therapy.

The DCRU, in collaboration with Medanta Duke Research Institute in New Delhi, India and the Duke-affiliated early phase research unit in Singapore comprise an international network designed to accelerate clinical research and development, as well as evaluation of human biology, diseases, drugs and devices, according to Duke.